Spectinomycin
Treatment for Gonorrhea
Typical Dosage: 2 g IM single dose
Effectiveness
97%
Safety Score
70%
Clinical Trials
100
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2 g IM single dose
Time to Effect
Rapid
Treatment Duration
Single IM dose
Evidence Quality
HIGHNumber Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$300
Side Effect Mgmt:$5
Total Annual:$380
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$391.75
Cost per Remission
$391.75
Prescription Access Economics
Annual Societal Loss per Patient
$355
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$300/year
Time Cost
$60/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$75/year
Potential OTC Price
$100/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
MODERATESpectinomycin Outcomes
for Gonorrhea
Efficacy Outcomes
Overall Effectiveness
+97%
Response Rate
+97%
Remission Rate
+97%
Common Side Effects
Injection site pain
+15%
Nausea
+2%
Dizziness
+1%
Fever
+1%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov